Used in research settings as a selective inhibitor of the menin-MLL (mixed lineage leukemia) protein-protein interaction, making it a valuable tool compound in studies targeting MLL-rearranged leukemias. It helps disrupt oncogenic gene expression pathways, supporting the development of potential epigenetic cancer therapies. Its high specificity allows for probing menin-dependent cellular mechanisms without broad off-target effects, particularly in hematological cancer models.